Syros rises after $50M IPO

Syros Pharmaceuticals Inc. (NASDAQ:SYRS) gained $5.65 (45%) to $18.15 on its first day of trading Thursday after raising $50 million through the sale of 4 million shares at $12.50 in an IPO. The price valued Syros at $284.5 million.

Earlier this month, the company filed to raise up to $69 million. Last week, it said it planned to sell 4 million shares at $14-$16. Cowen, Piper Jaffray, JMP Securities and Wedbush are underwriters. ...